-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Raises Price Target to $6

Benzinga·11/18/2025 15:42:00
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and raises the price target from $4 to $6.